Publications
5808 Results
- Journal / Conference
- British Journal of Cancer 110(4):882-887;
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID24423918
- PMC
- PMC3929880
- Study Number(s)
- S0941
SWOG S0941: A phase II study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
- Journal / Conference
- Journal of Clinical Oncology 32(12):1242-2348;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24663049
- PMC
- PMC3986386
- Study Number(s)
- E1905
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia and myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905
- Journal / Conference
- Annals of Thoracic Surgery 98(2):402-410;
- Year
- 2014
- Research Committee(s)
- Lung
- PMID
- PMID24980603
- PMC
- PMC4122593
- Study Number(s)
- S0220
Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup trial S0220
- Journal / Conference
- The Pharmacogenomic Journal 14(3):241-247;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID23999597
- PMC
- PMC3940691
- Study Number(s)
- S0221
Germline genetic variants in ABCB1, ABCC1, and ALDH1A1 and risk of hematological and gastrointestinal toxicities in a SWOG phase III trial S0221 for breast cancer
- Journal / Conference
- Journal of Clinical Oncology 32(11):1136-1142;
- Year
- 2014
- Research Committee(s)
- Genitourinary
- PMID
- PMID24616308
- PMC
- PMC3970171
- Study Number(s)
- S0421
Circulating tumor cell (CTC) counts are prognostic of overall survival in SWOG S0421: docetaxel with or without atrasentan for metastatic castration resistant prostate cancer
- Journal / Conference
- Journal of Clinical Oncology 32(33):3771-3778;
- Year
- 2014
- Research Committee(s)
- Melanoma
- PMID
- PMID25332243
- PMC
- PMC4226807
- Study Number(s)
- S0008
Southwest Oncology Group S0008: A Phase III trial of High-Dose Interferon Alfa-2b Versus Cisplatin, Vinblastine, and Dacarbazine DTIC, Plus Interleukin-2 and Interferon in Patients With High-Risk Melanoma-An Intergroup Study of Cancer and Leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
- Journal / Conference
- Cancer Immunology Research 2(10):981-987;
- Year
- 2014
- Research Committee(s)
- Melanoma
- PMID
- PMID24994597
- PMC
- PMC4185232
- Study Number(s)
- SWOG-9035
Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival
- Journal / Conference
- Journal of Clinical Oncology 32(11):1143-1150;
- Year
- 2014
- Research Committee(s)
- Genitourinary
- PMID
- PMID24590644
- PMC
- PMC3970172
- Study Number(s)
- CTSU/C90202
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202
- Journal / Conference
- Journal of Urology 192(4):1094-1099;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID24747090
- PMC
- PMC4194238
- Study Number(s)
- S0000
Is there a role for body mass index in assessment of prostate cancer risk on biopsy?
- Journal / Conference
- Lancet 383(9928):1561-1571;
- Year
- 2014
- Research Committee(s)
- Lung
- PMID
- PMID24576776
- PMC
- PMC4022989
- Study Number(s)
- SWOG-9015, S9900